Daxor Corporation DXR
Set alert
As of Nov 3, 10:26 AM ET
- YTD
- -41.08%
- 1 year
- -33.61%
- Open
- 8.89
- Prev close
- 9.00
- Mkt cap
- 50.73M
- Vol
- 15.33K
- Avg vol
- 20.03K
- EPS
- 1.10
- P/E
- 7.90
- Div yield
- 0.00%
More statistics
- Low
- 8.67
- High
- 8.95
- Forward P/E
- 0.00
- Beta
- -0.54
- Short ratio
- 0.60
- Inst. own
- 1.94%
- Dividend
- 0.00
- Ex-div date
- Jan 4, 2018
- Earnings
- Mar 28, 2012
- 50-d avg
- 8.96
- 200-d avg
- 9.04
- 1y target
- 23.38
News
1 day ago defenseworld.net
Daxor Corporation (NASDAQ:DXR) Shares Shorted: Short Interest Down 51.5% in October
Daxor Corporation (NASDAQ: DXR - Get Free Report) was the target of a large drop in short interest in the month of October. As of October 15th, there was short interest totaling 3,374 shares, a drop…
2 weeks ago globenewswire.com
Daxor Accelerates Commercial Expansion of Next-Gen Blood Volume Diagnostic Platform at MedAxiom CV Transforum Fall '26
FDA-cleared BVA™ technology delivers lab-accurate precision to optimize cardiovascular service lines, reduce 30-day readmissions, and lower cost of care. Key Highlights: Commercial Acceleration:…
-
2 weeks ago benzinga.com
Daxor Announces New Clinical Studies Validate BVA Technology In High-Acuity Heart Failure Populations To Enhance Care At HFSA 2026 Annual Scientific Meeting
Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology, today announced significant clinician interest and compelling clinical validation following the Heart Failure…
2 weeks ago globenewswire.com
Daxor Announces Strong Commercial Interest and New Clinical Data at HFSA 2026
New Clinical Studies Validate BVA™ Technology in High-Acuity Heart Failure Populations to Enhance Care OAK RIDGE, TN, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global…
3 weeks ago globenewswire.com
Daxor to Showcase Blood Volume Analysis Platform at ASN Kidney Week 2026
Making its ASN debut, Daxor's BVA™ technology delivers precise volume measurement to optimize fluid management and improve complex kidney care. Key Highlights: Commercial Presence: Daxor exhibiting…
3 weeks ago defenseworld.net
Daxor Corporation (NASDAQ:DXR) Sees Large Growth in Short Interest
Daxor Corporation (NASDAQ: DXR - Get Free Report) was the target of a significant growth in short interest during the month of September. As of September 30th, there was short interest totaling 6,959…
1 month ago globenewswire.com
Daxor to Showcase Next-Gen Blood Volume Analyzer and New Clinical Data at HFSA 2026
FDA 510(k)-cleared next-generation diagnostic platform delivers 3x faster results with 50% less blood, setting a new standard for data-driven heart failure management. Key Highlights: Commercial…
1 month ago globenewswire.com
Daxor Corporation to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
Oak Ridge, TN, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh…
2 months ago globenewswire.com
Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter
Oak Ridge, TN, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today provides a mid-year corporate and financial update…
3 months ago globenewswire.com
Daxor Broadens Outpatient Footprint with Initiation of ezBVA Lab Diagnostic Services in Kansas
Commercial Momentum Accelerates as Health System Adopts Turnkey Blood Volume Analysis via CLIA-Certified Send-Out Model OAK RIDGE, TN, July 29, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq:…
3 months ago globenewswire.com
Daxor Corporation Announces First-Time Exhibition at the 14th Annual Dysautonomia International Conference in The Woodlands, Texas
Daxor to Showcase How BVA Provides the Objective Plasma and Red Blood Cell Data Needed to Target Dysautonomia Therapy Oak Ridge, TN, July 07, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR),…
5 months ago globenewswire.com
Daxor Corporation Receives U.S. Patent for Breakthrough Remote Blood Volume Monitor
New Technology Expands Daxor's Diagnostic Capabilities to Enable Continuous, Remote Tracking of Blood Volume Status Using Wearable Sensors, Enhancing Care for Heart Failure, Syncope, Anemia, and…
6 months ago globenewswire.com
Daxor Leverages MedAxiom CV Transforum Spring'26 to Accelerate Commercial Adoption of Blood Volume Analysis
Oak Ridge, TN, April 28, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will exhibit its Blood Volume Analyzer…
6 months ago globenewswire.com
Daxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center
Oak Ridge, TN, April 08, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, continues its strategic expansion with the launch of a new…
7 months ago globenewswire.com
Daxor's Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026
OAK RIDGE, TN, March 26, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces that new clinical data evaluating the…
7 months ago globenewswire.com
Daxor Corporation to Showcase Next-Generation Portable Blood Volume Analyzer at ACC.26; Highlighting Clinical Outcomes and Reduced Readmissions
Oak Ridge, TN, March 17, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces its participation as an exhibitor at the…
7 months ago seekingalpha.com
Daxor Corporation (DXR) Presents at IAccess Alpha Virtual Best Ideas Spring Investment Conference 2026 Prepared Remarks Transcript
Daxor Corporation (DXR) Presents at IAccess Alpha Virtual Best Ideas Spring Investment Conference 2026 Prepared Remarks Transcript
7 months ago globenewswire.com
Daxor to Debut New Rapid, Portable Blood Volume Analyzer at SCCM 2026 Critical Care Congress
Advancing Precision Fluid Management in the ICU to Reduce Mortality and Hospital Length of Stay Oak Ridge, TN, March 10, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in…
7 months ago globenewswire.com
Daxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026
Oak Ridge, TN, March 09, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces that CEO and President Michael Feldschuh will…
8 months ago globenewswire.com
Daxor Corporation Reports 2025 Fiscal Year Results: Operating Revenue Up 45%, Net Asset Value Rises to $9.07 Per Share
Strategic Realignment to Clinical Growth Supported by FDA 510(k) Clearance for Next-Generation Blood Volume Analyzer Oak Ridge, TN, March 03, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR),…
-
5 years ago benzinga.com
64 Biggest Movers From Friday
Gainers Senseonics Holdings, Inc. (NYSE: SENS) jumped 42% to settle at $2.91 on Friday after the company disclosed results from a PROMISE study evaluating its Eversense CGM System for up to 180 days.…
-
5 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
Before 10 a.m. ET Friday, 62 stocks made new 52-week lows.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Wednesday
On Wednesday, 111 companies set new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Thursday
This morning 168 companies reached new 52-week highs.
-
6 years ago benzinga.com
50 Stocks Moving In Tuesday's Mid-Day Session
50 Stocks Moving In Tuesday's Mid-Day Session
-
6 years ago benzinga.com
Mid-Day Market Update: Crude Oil Rises Over 3%; Novavax Shares Plunge
Mid-Day Market Update: Crude Oil Rises Over 3%; Novavax Shares Plunge
-
7 years ago benzinga.com
70 Stocks Moving In Wednesday's Mid-Day Session
70 Stocks Moving In Wednesday's Mid-Day Session